THE
FUTURE
OF CANNABIS SCIENCE
Stop guessing what your cannabis products actually do. Canalytics reveals the hidden science behind effects—predicting therapeutic and recreational outcomes from COA data. Empower brands, breeders, cultivators, labs, and dispensaries with actionable intelligence that drives sales, builds loyalty, and maximizes market value.
Prove the Effects.
Lead the Industry
The cannabis industry's most advanced cannabis analysis platform. Canalytics analyzes your lab tested COA data against 10,213+ scientific studies to reveal exactly what your products do—and who they're perfect for. From phenohunting and genetic optimization to customer matchmaking and premium product development, we empower the entire supply chain with insights that drive profitability, differentiation, and customer loyalty. Join industry leaders who've turned cannabis science into unmatched competitive advantage.
Solutions for
Brands
Transform products into premium experiences with scientifically validated effect profiles. Match customers to perfect strains, develop targeted product lines, and command premium prices with insights backed by 10,213+ studies.
Breeders
Breed with scientific precision using effect-driven genetic analysis. Predict phenotype outcomes, accelerate selection, and develop premium genetics that command higher prices through data-backed effect profiles.
Cultivators
Optimize your genetic portfolio with comprehensive effect analysis. Compare hundreds of phenotypes, identify top performers, eliminate weak strains, and grow genetics that align with market demand and maximize profitability.
Dispensaries
Integrate effect-driven product matching directly into your POS and online store. Empower budtenders with scientific insights, increase average transaction value, and build lasting customer loyalty through perfect product recommendations.
Testing Labs
Elevate from compliance vendor to strategic partner with effect-enhanced COA reports. Integrate seamlessly with your LIMS, increase revenue per sample, and provide clients with actionable market intelligence that competitors can't match.
Processors
Engineer precision-targeted formulations for concentrates, edibles, tinctures, and topicals. Optimize terpene blends, reduce R&D costs, ensure batch consistency, and command premium prices with scientifically validated effect profiles.
Transforming Every Stage of the Cannabis Supply Chain
Canalytics serves the entire cannabis ecosystem with effect prediction technology that drives measurable results. Breeders develop premium genetics faster. Cultivators optimize portfolios for market demand. Processors create precision-targeted formulations. Testing labs add high-margin services. Dispensaries increase transaction values through perfect product matching. Canalytics delivers the scientific validation and competitive intelligence that separate market leaders from the rest.
Therapeutic Effects Analyzed
Adult Use Effects Analyzed
Plus 17 Additional Effects
Beyond the therapeutic and adult use effects shown above, Canalytics analyzes 17 additional cannabis effects to provide the most comprehensive strain profiling in the industry.
Designer Cannabis Formulas
100+ Scientifically Engineered Effect Profiles - License, Partner, or Purchase
Canalytics has reverse-engineered 100+ precision cannabinoid and terpene formulas from 10,213+ studies, each targeting specific therapeutic and recreational effects. Whether you're formulating concentrates, edibles, tinctures, topicals, or seeking organic flower genetics that match these designer-grade profiles, our technology empowers you to create premium products across every cannabis category. Available for licensing, partnership, or direct purchase—transform your product line with scientifically validated formulas that deliver consistent, predictable effects.
The Science Behind Cannabis Effect Analysis
Meet the multidisciplinary team working on the industry leading cannabis effect analysis. Our researchers, doctors scientists, data engineers, and cannabis industry veterans combine rigorous academic research with real-world application expertise. From decoding cannabinoid-terpene interactions to building comprehensive cannabis analysis and insights systems, we've assembled the talent that's redefining how the industry understands, validates, and commercializes cannabis. Every solution we deliver is backed by peer-reviewed science and designed for industry wide implementation.
Matthew Widmer
Matthew brings over two decades of extensive research and technological innovation to Canalytics. His multidisciplinary background in neuroscience, cognitive science, and computer science, and comprehensive analysis of 7,000+ studies on the endocannabinoid system and cannabinoid-terpene effect synergy provide a robust scientific foundation for Canalytics' cutting-edge algorithmic analysis systems. Matthew brings an impressive track record in designing sophisticated computational systems. In 2007, he spearheaded the development of a Crestron automation system with 5,000+ relays. Throughout his career, Matthew has been at the forefront of advancements ranging from digital therapeutics and VR/AR to innovative health-boosting systems utilizing emotion tracking feedback loops for personalized recommendations.
Brent Stevens
Brent Stevens, co-founder of Canalytics, brings 23 years of expertise in the cannabis industry, spanning innovative product development, building labs, cultivation facilities, dispensaries, managing medical grows and founding multiple global brands. Including founding, patenting and spearheading the award-winning Flower Mill company, now a staple in the industry. With a background in c-suite company development and sales, Brent also founded The Shire Group, streamlining operations and compliance for businesses. Committed to social responsibility, he supports initiatives providing cannabis to communities in need. Brent's laser focus on improving cannabis quality and experience across therapeutic and adult use cannabis has driven advancements shaping the industry.
Dr. Janice Knox, MD, MBA
Dr. Janice Vaughn-Knox, MD, MBA is a retired board certified anesthesiologist, endocannabinologist, and certified cannabinoid medicine specialist. Dr. Janice is one of a family of 4 clinicians that believes science, research and technology will disrupt health care as it has been known. The future of cannabis medicine will depend on how well the physiology of the body is known and the correct clinical application of the pharmacology of cannabis and other botanicals.
Dr. Jessica Knox, MD, MBA, MPH
Dr. Jessica Knox is a board-certified preventive medicine physician with 6 years of clinical experience in cannabinoid medicine. Dr. Jessica is a co-founder of several organizations, including co-founder of Doctors Knox, Inc. and Pivital Holdings; and the Association for Cannabis Health Equity and Medicine (ACHEM), the first national medical association for BIPOC professionals seeking to heal themselves and their communities through cannabis education, advocacy, and application.
Dr. Rachel Knox, MD, MBA
Dr. Rachel Knox, MD, MBA is an endocannabinologist specializing in cannabinoid medicine, and a policy expert on cannabis and psychedelic health equity. She's the creator and president of the Cannabis Health Equity Movement (CHEM)®, comprising the Association for Cannabis Health Equity and Medicine (ACHEM), CHEM Allyance, and CHEM Cooperative; and is co-founder of Doctors Knox, Inc. and Pivital Holdings. She is the immediate past chair of the Oregon Cannabis Commission, immediate past Vice Chair and Equity Chair of the Oregon Psilocybin Advisory Board, and a founding board member of Cannabis Regulators of Color Coalition (CRCC).
Dr. David Knox, MD
Dr. David Knox is a board certified emergency medicine physician with nearly a decade of clinical experience in cannabinoid medicine. Along with his family, Dr. David founded Doctors Knox, Inc., the American Cannabinoid Clinics, delivering precision cannabinoid medicine to patients; and Pivital Edu, which develops comprehensive training for healthcare professionals in the ECS, endocannabinology and cannabinology.
Doctor Testimonials
"Canalytics is the realization of my vision for the cannabis industry, which is why I am thrilled to join the company's Scientific Advisory Board. Canalytics is pioneering the integration of science, physiology, and technology to deliver data-backed solutions targeting medical conditions—exactly what I've been eagerly anticipating for the past decade. Their technology eliminates guesswork for the entire supply chain by illuminating the intricacies of cannabis' effects."
"As an endocannabinologist, I'm excited to contribute expertise to Canalytics' Scientific Advisory Board, driving innovation and impact. Canalytics adeptly combines scientific rigor with innovation illuminating cannabis' complexities through proprietary tech. This enables unprecedented customization - from breeding, product develop, product recommendations to novel formulations and increased efficacy in cannabis medicine."
"Cannabis is a polypharmacy with multiple cannabinoids, terpenes, and phytochemicals. Precision in clinical use has been an issue, addressed through trial-and-error to find optimal results per patient. Canalytics' integration of science and technology offers great potential for a better approach to personalized botanical medicine."
"Canalytics delivers a groundbreaking solution that clinical endocannabinologists have long awaited - sophisticated tech offering novel insights into diverse phytochemicals and their impact on human physiology. This unlocks the potential of personalized botanical medicine and self-care at an unprecedented scale. I am honored to help guide the development and deployment of this revolutionary technology."
Pioneering Cannabis Effect Science
Canalytics transforms complex cannabinoid and terpene data into actionable intelligence. Our team of scientists, data engineers, and cannabis experts doesn't just analyze genetics—we decode the science of effects across the entire supply chain. From breeders optimizing phenotypes to dispensaries matching customers with perfect products, we deliver the precision, consistency, and competitive advantage that defines market leaders. Partner with the team that's setting the industry standard for effect prediction and scientific validation.